PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...

Barclays raised the firm’s price target on PTC Therapeutics (PTCT) to $45 from $43 and keeps an Equal Weight rating on the shares. After ...

Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...

Vishay has introduced an automotive-rated series of positive temperature coefficient (PTC) in-rush current thermistors.

Travel sourcing and consultancy group Partnership Travel Consulting has named former Corporate Travel Management executive Maureen Brady as its chief commercial officer, a new position for the group.

PTC's SaaS transition is expected to enhance long-term cash flows but may cause near-term valuation contractions and revenue volatility. Despite strong operational performance and industry ...

Nov 6 (Reuters) - Industrial software maker PTC (PTC.O), opens new tab forecast first-quarter revenue below estimates on Wednesday, signaling continued weakness in demand for its industrial design ...

This is the first gene therapy for AADC deficiency to receive US regulatory approval and the first that can be administered directly to the brain.

PTC (NASDAQ: PTC) today announced that its Board of Directors has authorized the repurchase of up to $2 billion worth of PTC ...

This collaboration will integrate Configit's Configuration Lifecycle Management (CLM) solutions with PTC's Product Lifecycle Management (PLM) systems, offering a comprehensive and cohesive ...

Q4 2024 Earnings Conference Call November 6, 2024 5:00 PM ETCompany ParticipantsMatt Shimao - Head of Investor RelationsNeil Barua ...

In the latest quarter, 6 analysts provided ratings for PTC PTC, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by analysts ...